During the past decade, Mercy Health Cincinnati conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Health Cincinnati" #1 collaborator was "BTG International Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Health Cincinnati" are "Left Atrial Appendage Absent" (1 trials) and "Pulmonary Embolism and Thrombosis" (1 trials). Many other conditions were trialed in "Mercy Health Cincinnati" in a lesser frequency.

Most popular intervention types in "Mercy Health Cincinnati" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "AtriClip" (1 trials) and "EkoSonic Endovascular System with thrombolytic" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Health Cincinnati" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Mercy Health Cincinnati". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Mercy Health Cincinnati, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Health Cincinnati, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".